Proactive Investors - Run By Investors For Investors

Roth Capital Partners maintains Buy rating, $10 price target for cannabis company Hexo Corp

But Analyst Scott Fortune lowered his revenue and earnings forecasts for the Quebec-based cannabis company
hemp
Hexo should benefit from entering the US market (eight states) with its CBD products

Roth Capital Partners on Friday maintained its Buy rating and $10 price target for Hexo Corp (TSE:HEXO)(NYSEAMERICAN:HEXO), a day after the Canadian cannabis company reported fiscal third-quarter results.

But Analyst Scott Fortune lowered his revenue and earnings forecasts for Hexo, calling the company’s 3Q earnings “soft.”

Hexo, based in Gatineau, Quebec, reported net revenue of US$13 million, while Fortune expected US$15.7 million. The company also missed on adjusted gross profit — US$6.4 million versus an expected US$7.5 million.

READ: HEXO sees huge revenue jump in the third quarter but still misses estimates

As a result, Fortune wrote that he’s reducing his fiscal year 2019 revenue forecast by US$4.2 million to US$59.6 million, while maintaining his fiscal year 2020 forecast for US$63.8 million in revenue.

Despite lowering his revenue forecast, Fortune remains optimistic that Hexo “will gain market share in becoming a large tier” licensed producer.

“Although soft quarterly results, management reiterated FY20 guidance of $400M revenues and remains committed to break even in the FY20 timeframe,” he wrote.

Fortune noted that Hexo should benefit from entering the US market (eight states) with its CBD products and vape sales as well as increase annual production of cannabis up to 150,000 kilograms, “which justifies the doubling in revenue guidance in our opinion.”

CIBC downgrade

In related news, according to the Fly, CIBC Capital Markets analyst John Zamparo downgraded Hexo to Neutral from Outperformer, saying he doubts the company can achieve US$400 million in revenue in fiscal 2020.

He lowered his price target to C$8.50 from C$9.50 

Hexo’s stock recently traded down 4.2% to US$5.65 a share on the NYSE and fell 3.1% to C$7.57 in Toronto.

Within the last 12 months, ROTH has received compensation for investment-banking services from Hexo.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full HEXO profile View Profile

Hexo Corporation Timeline

Related Articles

medicinal cannabis concept
January 30 2019
Zelda has released its December quarterly report confirming multiple trials are on track.
cannabis leaf
May 08 2019
The company plans to leverage its portfolio of brands as well as its distribution network of more than 39,000 European pharmacies to maximize margins and profitability
cannabis facility
January 23 2019
The company is breaking into the large and lucrative market in the golden state
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use